All In Biotech

Free tool

FAERS Monitor: Tekturna

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021985 or its brand name (Tekturna, Aliskiren Hemifumarate). Reports on generic versions are filed under their own applications.

Reports

6,026

Serious

4,257

71% of reports

Hospitalization

1,934

Death reported

746

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea666
  • blood pressure increased626
  • fatigue617
  • headache616
  • fall594
  • asthenia587
  • cough543
  • dizziness541
  • dyspnoea529
  • malaise527
  • vomiting470
  • diarrhoea463
  • pyrexia421
  • cerebrovascular accident408
  • drug ineffective375

Reports by year received

View as table
YearReports
2007628
2008728
2009285
2010384
2011607
2012734
2013401
2014254
2015272
2016233
2017121
2018223
2019195
2020145
202190
2022152
2023120
2024206
2025155
202693

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,133 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
blood pressure increasedSignal62614.313.37,784
cerebrovascular accidentSignal4088.47.72,677
coughSignal5436.86.22,695
fallSignal5946.25.82,645
astheniaSignal5875.55.12,167
pyrexiaSignal4214.33.91,059
malaiseSignal5274.23.91,306
dizzinessSignal5413.83.51,133
vomitingSignal4703.53.2851
headacheSignal6163.43.21,090
dyspnoeaSignal5293.33.0850
nauseaSignal6662.92.7882
fatigueSignal6172.82.6721
diarrhoeaSignal4632.52.3430
drug ineffective3751.00.90

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.